EQT to buy Swedish drug maker Recipharm: Bloomberg

EQT has agreed to acquire Recipharm, a Swedish pharmaceuticals company, reported Bloomberg.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this